Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Officer Henn Matthew R. converted options into 12,622 shares and sold $2,749 worth of shares (3,984 units at $0.69), increasing direct ownership by 13% to 75,885 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.